| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
4,813 |
4,286 |
$330K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
5,410 |
4,246 |
$128K |
| 87481 |
|
5,636 |
4,152 |
$84K |
| 87500 |
|
4,820 |
4,297 |
$25K |
| 87511 |
|
4,530 |
4,009 |
$22K |
| 87640 |
|
4,742 |
4,224 |
$21K |
| 87653 |
|
4,743 |
4,226 |
$20K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
283 |
275 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
265 |
257 |
$3K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
222 |
213 |
$3K |
| 87556 |
|
131 |
126 |
$2K |
| 87529 |
|
129 |
124 |
$2K |
| 87496 |
|
112 |
107 |
$1K |
| 87532 |
|
49 |
43 |
$337.50 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
13 |
12 |
$0.00 |